Patents by Inventor Kelly Frazier
Kelly Frazier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11980565Abstract: Introduced here are pressure-mitigation apparatuses for mitigating the pressure applied to a human body by the support surface of an object. The pressure-mitigation apparatus can include a series of chambers that can be individually controlled to vary the pressure therein. By varying the chamber pressure, the main point of pressure applied by the support surface to the human body may be moved across the surface of the human body. An attachment apparatus may be used to securely adhere the pressure-mitigation apparatus to the support surface.Type: GrantFiled: March 25, 2019Date of Patent: May 14, 2024Assignee: TurnCare, Inc.Inventors: Rafael Paolo Squitieri, Robert Charles Deutsch, Steven Bruce Frazier, Robert Loiacono, Linda Seaman, Erica Kelly
-
Patent number: 11981099Abstract: Introduced here are methods, apparatuses, and systems for mitigating the contact pressure applied to a human body by the surface of an object, such as a chair, bed, or table. A pressure-mitigation apparatus can include a series of chambers whose pressure can be individually varied. When placed between a patient and a contact surface, a controller can vary the contact pressure on the human body by controllably inflating one or more chambers, deflating one or more chambers, or any combination thereof. By monitoring the pressure in each chamber over time, the controller can also gain an enhanced understanding of movement(s) performed by the human body when positioned on the pressure-mitigation apparatus.Type: GrantFiled: January 25, 2022Date of Patent: May 14, 2024Assignee: TurnCare, Inc.Inventors: Rafael Paolo Squitieri, Robert Charles Deutsch, Steven Bruce Frazier, Robert Loiacono, Linda Seaman, Erica Kelly
-
Publication number: 20240104577Abstract: A method for renewing and enhancing device protection accounts is provided, the method including firstly receiving a data file containing account information at predetermined intervals from a protection carrier, secondly referencing the data file when an account subscriber contacts a provider, thirdly determining whether the subscriber is eligible for account renewal and enhancement; and fourthly notifying the subscriber that account renewal and enhancement eligibility has been determined.Type: ApplicationFiled: May 30, 2023Publication date: March 28, 2024Applicant: Asurion LLCInventors: Guy Cartwright, Pat Moody, Kelly Frazier
-
Publication number: 20230030252Abstract: A method for renewing device protection accounts is provided, the method including at least the receiving of a data file containing account information at predetermined intervals from a protection carrier; referencing the data file when an account subscriber contacts a provider; determining whether the subscriber is eligible for account renewal; and notifying said subscriber that account renewal eligibility has been determined.Type: ApplicationFiled: December 16, 2021Publication date: February 2, 2023Applicant: Asurion LLCInventors: Guy Cartwright, Pat Moody, Kelly Frazier
-
Patent number: 8563549Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.Type: GrantFiled: May 14, 2012Date of Patent: October 22, 2013Assignee: Novartis AGInventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Ataliah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel J. Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Meritt, Charles Voliva, Marion Wiesmann, Xiahua Xin
-
Publication number: 20120225859Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.Type: ApplicationFiled: May 14, 2012Publication date: September 6, 2012Applicant: NOVARTIS AGInventors: Matthew BURGER, Zhi-Jie NI, Sabina PECCHI, Gordana ATALLAH, Sarah BARTULIS, Kelly FRAZIER, Aaron SMITH, Joelle VERHAGEN, Yanchen ZHANG, Allan WAGMAN, Simon NG, Keith PFISTER, Daniel POON, Alicia LOUIE, Teresa PICK, Paul BARSANTI, Edwin IWANOWICZ, Wendy FANTL, Thomas HENDRICKSON, Mark KNAPP, Hanne MERRITT, Charles VOLIVA, Marion WIESMANN, Xiaohua XIN
-
Patent number: 8217035Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.Type: GrantFiled: January 22, 2007Date of Patent: July 10, 2012Assignee: Novartis AGInventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Atallah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Merritt, Charles Voliva, Marion Wiesmann, Xiaohua Xin
-
Publication number: 20100249126Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.Type: ApplicationFiled: January 22, 2007Publication date: September 30, 2010Applicant: NOVARTIS VACCINES AND DIAGNOSTICS INC.Inventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Atallah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel J. Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Meritt, Charles Voliva, Marion Wiesmann, Xiahua Xin
-
Publication number: 20100075965Abstract: Phosphatidylinositol (PI) 3 kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, phospholipid kinases, G-protein coupled receptors, and phosphatases.Type: ApplicationFiled: February 14, 2007Publication date: March 25, 2010Inventors: Zhi-Jie Ni, Sabina Pecchi, Matthew Burger, Wooseok Han, Aaron Smith, Gordana Atallah, Sarah Bartulis, Kelly Frazier, Joelle Verhagen, Yanchen Zhang, Ed Iwanowicz, Tom Hendrickson, Mark Knapp, Hanne Merritt, Charles Voliva, Marion Wiesmann, Darren Mark Legrand, Ian Bruce, James Dale, Jiong Lan, Barry Levine, Abran Costales, Jui Liu, Teresa Pick, Daniel Menezes
-
Patent number: D406648Type: GrantFiled: January 27, 1998Date of Patent: March 9, 1999Inventor: Calvine Kelly Frazier
-
Patent number: D739735Type: GrantFiled: March 6, 2014Date of Patent: September 29, 2015Assignee: Beech-Nut Nutrition CompanyInventors: Christopher Darling, Robert Harvey, Jodi Breuer, Brody Boyer, Kelly Frazier, Eric Staples, Michelle Hayward, Nancy Mines
-
Patent number: D754544Type: GrantFiled: February 12, 2014Date of Patent: April 26, 2016Assignee: Beech-Nut Nutrition CompanyInventors: Christopher Darling, Robert Harvey, Jodi Breuer, Brody Boyer, Kelly Frazier, Eric Staples, Michelle Hayward, Nancy Mines
-
Patent number: D756789Type: GrantFiled: March 26, 2014Date of Patent: May 24, 2016Assignee: Beech-Nut Nutrition CompanyInventors: Christopher Darling, Robert Harvey, Jodi Breuer, Brody Boyer, Kelly Frazier, Eric Staples, Michelle Hayward, Nancy Mines